Full name
PROVISUS BADANIA KLINICZNE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
PROVISUS BADANIA KLINICZNE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. RĘDZIŃSKA 112, 42-209 CZĘSTOCHOWA
TAX ID9492242830
Rate company:
PROVISUS BADANIA KLINICZNE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9492242830
KRS0000838426
Share capital5,000.00 zł
address
UL. RĘDZIŃSKA 112, 42-209 CZĘSTOCHOWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9492242830
REGON
385937547
KRS
0000838426
Legal form
limited liability company
Register Address
UL. RĘDZIŃSKA 112, 42-209 CZĘSTOCHOWA
Date of registration in KRS
2020-04-20
Date of commencement of economic activity
2020-04-20
Act signature
CZ.XVII NS-REJ.KRS/2954/20/262/ADE
Pkd codes
86.10.Z - Hospital activities
47.74.Z - Retail sale of medical and orthopedic products
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90.A - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
Payer VAT status
Active
Vat list bank account(s)
PL38 9256 0004 0725 0633 2000 0040 
PL72 9256 0004 0725 0633 2000 0010 
PL43 1020 1664 0000 3502 0642 9858 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale  | 0,2 | 0,4 | 0,9 | 129,1 |
Gross profit (loss) | 0,2 | 0,4 | 0,9 | 128,8 |
EBITDA | 0,3 | 0,8 | 1,2 | 43,5 |
Short time liabilities | 0,2 | 0,5 | 0,4 | -28,8 |
Other operating costs | 0 | 0 | 0 | -85,3 |
Equity capital | 0,2 | 0,5 | 1,4 | 160,3 |
Operating profit (EBIT) | 0,2 | 0,4 | 0,9 | 126,6 |
Assets | 0,4 | 1,3 | 1,9 | 51,5 |
Net profit (loss) | 0,2 | 0,4 | 0,9 | 139,6 |
Cash | 0,1 | 0,2 | 0,3 | 26,5 |
Net income from sale | 3,2 | 4 | 4,9 | 20,8 |
Liabilities and provisions for liabilities | 0,3 | 0,7 | 0,5 | -28,4 |
Working assets | 0,3 | 0,5 | 0,7 | 22,8 |
Other income costs | 0 | 0 | 0 | 57,4 |
Depreciation | 0,1 | 0,4 | 0,3 | -37,1 |
% | % | % | p.p. | |
Profitability of capital | 96,7 | 66,9 | 61,6 | -5,3 |
Equity capital to total assets | 40,9 | 42,3 | 72,8 | 30,5 |
Gross profit margin | 5,7 | 9,3 | 17,6 | 8,3 |
EBITDA Margin | 8,6 | 20,2 | 24 | 3,8 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 29 | 44 | 26 | -18 |
Current financial liquidity indicator | 1.170638918876648 | 1.094576358795166 | 1.8871972560882568 | 0,8 |
Net dept to EBITDA | -0.4130658507347107 | 0.052124977111816406 | -0.06985165178775787 | -0,2 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Blikpol
Sopot
DETOKSMED
Turek
Ewa Studniak
Szczecin
MARTA SERWIS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
POŁCZYN-ZDRÓJ
Jowita Bolewska Elektroradiolog
Nowa Sól